Press Release Solas Fiduciary Services expands further in Dubai SINGAPORE, Dec. 3, 2025 /PRNewswire/ — Solas Fiduciary Services (Solas), a privately… CISION PRNewswireDecember 3, 2025
foodpanda expands 'panda hearts' programme, reports 30% drop in rider accidents across Asia SINGAPORE, Dec. 3, 2025 /PRNewswire/ — foodpanda has achieved a 30% reduction… CISION PRNewswireDecember 3, 2025
Simplifying cross-border business: Statrys expands in Singapore with a unified CAB platform for SMEs SINGAPORE and HONG KONG , Dec. 3, 2025 /PRNewswire/ — Statrys, a leading provider of… CISION PRNewswireDecember 3, 2025
Press Release Hyundai Motor Group Unveils Production-Ready Autonomous Mobility Robot Platform 'MobED' at iREX 2025 MobED, Hyundai Motor Group Robotics LAB’s first mass-produced mobility robot platform, is… CISION PRNewswireDecember 3, 2025
Press Release EPG Earns Malaysia's BOMBA Approval, Paving the Way for Wider Modular Data Center Deployment in ASEAN SINGAPORE, Dec. 3, 2025 /PRNewswire/ — EPG, a leading provider of modular… CISION PRNewswireDecember 3, 2025
Press Release RSYC Lights Up Singapore's West Coast With The Nation's Most Illuminated Christmas Boat Parade SINGAPORE, Dec. 3, 2025 /PRNewswire/ — The Republic of Singapore Yacht Club… CISION PRNewswireDecember 3, 2025
Press Release DNAKE Donates Smart IP Intercom Systems to Habitat for Humanity Greater Los Angeles, Strengthening Home Security for Local Families LOS ANGELES, Dec. 3, 2025 /PRNewswire/ — DNAKE, a leading smart IP… CISION PRNewswireDecember 3, 2025
Celltrion announces U.S. FDA approval of 300mg strength of OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR® FDA approval of OMLYCLO® (omalizumab-igec) 300 mg/2 mL solution in a single-dose… CISION PRNewswireDecember 3, 2025
